Stifel Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Stifel Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2.71M	Buy	7,530 +2,303	+44%	+$772K	0.52%	73
2014 Q2	$1.48M	Hold	5,227	–	–	0.28%	98
2014 Q1	$1.57M	Sell	5,227 -3,800	-42%	-$1.17M	0.3%	96
2013 Q4	$2.48M	Buy	9,027 +210	+2%	+$60.4K	0.47%	77
2013 Q3	$2.76M	Hold	8,817	–	–	0.55%	67
2013 Q2	$1.98M	Buy	+8,817	New	+$2.05M	0.41%	82

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stifel Trust's REGN Position: Q3 2014 in Review

Stifel Trust increased its Regeneron Pharmaceuticals (REGN) stake by 44% in Q3 2014, buying an estimated $772K and bringing the position to 7,530 shares worth $2.71M. The position accounts for 0.52% of the portfolio, ranked #73.

Stifel Trust first reported a position in REGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.76M in Q3 2013. 473 funds tracked by Wall St. Rank hold REGN as of Q3 2014.

Stifel Trust held 7,530 shares of Regeneron Pharmaceuticals worth $2.71M as of Q3 2014.
Stifel Trust bought 2,303 Regeneron Pharmaceuticals shares in Q3 2014, an estimated $772K.
Regeneron Pharmaceuticals made up 0.52% of Stifel Trust's portfolio in Q3 2014, its #73 holding.
Stifel Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Stifel Trust's Regeneron Pharmaceuticals position peaked at $2.76M in Q3 2013.
473 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.